Across TCGA pan-cancer cohorts, BSX RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of BSX’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where BSX RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BSX is over-expressed in tumor.

HNSC and PRAD are the cancer types where BSX tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BSX RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	II,III,IV	+0.018	.025	6	view →
PRAD	All	All	+0.028	.022	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: BSX RNA expression & survival · all BSX data types